Presentation + Paper
2 March 2022 Label-free assessment of Panc-1 cells viability and changes in metabolic fluorophores followed by radiodynamic therapy (RDT)
Author Affiliations +
Abstract
Photodynamic therapy (PDT) is an established treatment which uses a photosensitiser drug and light source to destroy superficial lesions. This therapy is not applicable to deep-seated tumours due to limited light penetration. Recently, it has been found that replacing light in PDT with X-rays (thus named radiodynamic therapy (RDT)) can stimulate nano formulated photosensitiser drugs including Verteporfin and generate reactive oxygen species to kill the cancer cells. Herein, we investigated aspects of cellular metabolic processes after RDT in comparison with PDT and radiotherapy using label-free hyperspectral autofluorescence microscopy and image analysis. Biochemical signatures of metabolically relevant fluorophores (NAD(P)H, flavins, and optical-redox-ratio) were identified by developing a semi-unsupervised unmixing method combining supervised and unsupervised unmixing in a novel way.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Shannon Handley, Saabah B. Mahbub, Sandhya Clement, Ayad G. Anwer, and Ewa M. Goldys "Label-free assessment of Panc-1 cells viability and changes in metabolic fluorophores followed by radiodynamic therapy (RDT)", Proc. SPIE 11972, Label-free Biomedical Imaging and Sensing (LBIS) 2022, 1197202 (2 March 2022); https://doi.org/10.1117/12.2608479
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Nanoparticles

X-rays

Luminescence

Photodynamic therapy

Data modeling

Hyperspectral imaging

Cell death

Back to Top